NiK-004

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNiK-004
Drug Alias Namedual NK-1/NK-2 receptor antagonists (Brane)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 2 receptor antagonistsNeurokinin 1 receptor antagonists
TargetsNeurokinin 2 receptorNeurokinin 1 receptor
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNikem Research Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBrane Discovery SrlNikem Research Srl
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A